ストックスクリーナーアプリを入手
1.97
4.79%
0.09
アフターアワーズ：
1.97
前日終値:
$1.88
開ける：
$1.9
24時間の取引高:
2.96M
Relative Volume:
1.11
時価総額：
$686.13M
収益：
-
当期純損益:
$-75.80M
株価収益率:
-5.6286
EPS:
-0.35
ネットキャッシュフロー:
$-68.07M
1週間 パフォーマンス:
+12.57%
1か月 パフォーマンス:
-5.74%
6か月 パフォーマンス:
-18.93%
1年 パフォーマンス:
-26.77%
1日の値動き範囲:
$1.885
$2.00
1週間の範囲:
$1.7211
$2.08
52週間の値動き範囲:
$1.54
$3.97
Nuvation Bio Inc Stock (NUVB) Company Profile
名前
Nuvation Bio Inc
セクター
電話
(415) 754-3517
住所
357 TEHAMA STREET, FLOOR 3, SAN FRANCISCO
NUVB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NUVB
Nuvation Bio Inc
|
1.97 | 686.13M | 0 | -75.80M | -68.07M | -0.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
489.10 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.16 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
596.20 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
234.56 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
230.98 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Nuvation Bio Inc Stock (NUVB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-03-27 | アップグレード | Jefferies | Hold → Buy |
| 2024-03-26 | アップグレード | BTIG Research | Neutral → Buy |
| 2023-01-06 | ダウングレード | Jefferies | Buy → Hold |
| 2022-08-02 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2022-08-02 | ダウングレード | BTIG Research | Buy → Neutral |
| 2022-05-04 | 開始されました | H.C. Wainwright | Buy |
| 2021-10-15 | 再開されました | BTIG Research | Buy |
| 2021-04-06 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-03-08 | 開始されました | BMO Capital Markets | Outperform |
| 2021-03-08 | 開始されました | BTIG Research | Buy |
| 2021-03-08 | 開始されました | Cowen | Outperform |
| 2021-03-08 | 開始されました | Jefferies | Buy |
| 2021-03-08 | 開始されました | Wedbush | Outperform |
すべてを表示
Nuvation Bio Inc (NUVB) 最新ニュース
Is Nuvation Bio Inc. (NYSE:NUVB) the Best Biotech Penny Stock to Buy According to Hedge Funds? - Insider Monkey
Is Nuvation Bio Inc. (NUVB) the Top Healthcare Stock to Buy According to Billionaire David Einhorn? - Yahoo Finance
Wellington Management Group LLP Raises Position in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio Inc. (NYSE:NUVB) Shares Acquired by Vanguard Group Inc. - Defense World
David Hung Buys 300,000 Shares of Nuvation Bio Inc. (NYSE:NUVB) Stock - MarketBeat
Corebridge Financial Inc. Cuts Stake in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
American Century Companies Inc. Raises Stock Position in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
KLP Kapitalforvaltning AS Acquires Shares of 43,500 Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio Inc. (NUVB): Among Stocks Under $10 that Will Triple - Insider Monkey
Nuvation Bio CEO David Hung purchases $820,220 in company stock By Investing.com - Investing.com South Africa
Nuvation Bio CEO David Hung purchases $820,220 in company stock - Investing.com Australia
10 Stocks Under $10 that Will Triple - Insider Monkey
Institutional owners may take dramatic actions as Nuvation Bio Inc.'s (NYSE:NUVB) recent 8.8% drop adds to one-year losses - simplywall.st
Teacher Retirement System of Texas Increases Stock Position in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio to Present at the Jones Healthcare and Technology Innovation Conference - BioSpace
Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (WVE) and Nuvation Bio (NUVB) - The Globe and Mail
Nuvation Bio Inc (NYSE: NUVB) – An Analysis Is What You Need - stocksregister.com
Nuvation Bio (NYSE:NUVB) Reaches New 52-Week LowHere's Why - MarketBeat
Quantbot Technologies LP Decreases Stock Holdings in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio stock hits 52-week low at $1.7 amid market challenges - Investing.com
Swiss National Bank Buys 136,600 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Wedbush Reaffirms “Outperform” Rating for Nuvation Bio (NYSE:NUVB) - Defense World
Nuvation Bio Inc (NYSE: NUVB) Has Great Upside Potential - Stocks Register
Nuvation Bio (NYSE:NUVB) Receives Outperform Rating from Wedbush - The AM Reporter
Nuvation Bio Inc. (NYSE:NUVB) Stock Position Boosted by Charles Schwab Investment Management Inc. - Defense World
Nuvation Bio to Present New Nonclinical Data for Taletrectinib at the American Association for Cancer Research Annual Meeting 2025 - BioSpace
Nuvation Bio to Present Matching-adjusted Indirect Comparison Data for Taletrectinib vs. Crizotinib During Mini Oral Presentation at the European Lung Cancer Congress 2025 - BioSpace
Nuvation Bio Enters Supply Agreement With Asymchem For Taletrectinib - Marketscreener.com
Insider Stock Buying Reaches US$720.1k On Nuvation Bio - Yahoo Finance
Breakthrough Lung Cancer Treatment Comparison: Taletrectinib Shows Head-to-Head Data vs Standard Therapy - Stock Titan
Bank of New York Mellon Corp Buys 14,203 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio Sees Unusually High Options Volume (NYSE:NUVB) - Defense World
Nuvation Bio Inc (NYSE: NUVB) Is The Number One Stock Currently Moving. - Stocks Register
Is Nuvation Bio Inc. (NYSE:NUVB) the Most Oversold Penny Stocks to Buy According to Analysts? - Insider Monkey
Arizona State Retirement System Grows Position in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
10 Most Oversold Penny Stocks to Buy According to Analysts - Insider Monkey
Analysts Set Nuvation Bio Inc. (NYSE:NUVB) Target Price at $8.33 - Defense World
Nuvation Bio Inc (NUVB): Be Patient, You Will Learn - Stocks Register
Jones Trading Begins Coverage on Nuvation Bio (NYSE:NUVB) - Defense World
Q1 EPS Estimates for Nuvation Bio Decreased by HC Wainwright - Defense World
Jones Trading Initiates Coverage of Nuvation Bio (NUVB) with Buy Recommendation - Nasdaq
Nuvation Bio Positioned for Growth with Key Therapeutics and Strategic Leadership - TipRanks
Jones Trading sets $10 target for Nuvation Bio stock with Buy rating - Investing.com Australia
Jones Trading sets $10 target for Nuvation Bio stock with Buy rating By Investing.com - Investing.com South Africa
Nuvation Bio initiated with a Buy at JonesResearch - TipRanks
Nuvation Bio (NYSE:NUVB) Shares Gap Down Following Analyst Downgrade - Defense World
Nuvation Bio Inc (NUVB) 財務データ
収益
当期純利益
現金流量
EPS
2.51%
大文字化:
|
ボリューム (24 時間):